Term
|
Definition
|
|
Term
Goals of Conscious Sedation |
|
Definition
minimize or eliminate axiety and pain Keep patient able to respond purposfully Maintain normal Cardio/pulmonary function
|
|
|
Term
|
Definition
Patient is sedated but maintains consciousness maintains his or her airway Responds not anxious acceptable vital sign changes cooperative mild amnesia proptly resume pre-prosedural status
|
|
|
Term
Undesirable Effects of CS: |
|
Definition
Agitation and Combativeness unarousable sleep Bradycardia and Hypotension Apnea Airway Obstruction
|
|
|
Term
Where to use conscious Sedation? |
|
Definition
•Dental procedures •Endoscopy •Lumbar puncture •Cardioversion •Wound care •Minor surgical procedures •Device implantation •Anxious patients during diagnostic procedures |
|
|
Term
Work-up before Conscious Sedation |
|
Definition
HX (allergies, current meds, last oral intake) PE (height, wt., ausculations chest, airway) MEDS (anticoags, herbals) LABS (BMP for diabetic)
|
|
|
Term
Antagonist needed for CS. |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
Patien self report OR sings: muscle rigidity, tears, grimacing, faces, groaning, agitated, change in vitals
|
|
|
Term
|
Definition
|
|
Term
|
Definition
Lipid soluble with rapid distribution agonist on MU, Kappa and Delta Analgesia and some sedation alter mood and some perception of surrounding Hepatic metabolism (some renally excreted) Apnea possible bradycardia Altered hemodynamics GI, constipation, pruritis
|
|
|
Term
How do we chose drugs for conscious Sedation? |
|
Definition
|
|
Term
|
Definition
Onset: Minutes Peak: 20 minutes Duration: 2-4 hrs
based on the stats above this may not be the first choice |
|
|
Term
|
Definition
Onset: Minutes Peak: 5-7 minutes Duration: 2.5-4hrs
|
|
|
Term
|
Definition
Onset: Minutes Peak:15-30 min. Durations:2-4 hrs
|
|
|
Term
|
Definition
Onset:1-2 mintues Peak:3-5 mintues Half-life:3.7 hrs
look: onset and peak very quick |
|
|
Term
|
Definition
Onset: 1-2 minutes Peak: 5 minutes Duration: 2.7 hrs
short onset |
|
|
Term
|
Definition
onset: 2 minutes Peak: 5 minutes halflife: 1.5 hrs
notice that the half life is short..quick procedure |
|
|
Term
|
Definition
|
|
Term
|
Definition
MOA: Short acting hypnotic. No analgesic properties. Very lipophilic. Give as an emulsion. Contraindications: Soy, egg, or glycerol allergy. Adverse Reactions: Apnea, bradycardia, hypotension, GI; more serious effects are rare but might include pancreatitis or opisthotonus. Onset: 40 seconds; Duration 3-5 minutes. (quick in and out patient) Half-life: Two phases; the first phase is 2-4 minutes, while the second phase is 30-60 minutes. |
|
|
Term
|
Definition
MOA: GABA-agonist. Reticular activating system depression results in hypnosis. Precautions: Reduce dose elderly. Adverse Reactions: Transient myoclonus, mild GI irritation. Pain with injection, give with lidocaine. Half-life: 75 minutes (still quick) |
|
|
Term
|
Definition
MOA: Derivative of phencyclidine. Blocks glutamic acid excitation at NMDA receptors. Produces a dissociative anesthesia marked by catatonia, analgesia and amnesia. Derivative of PCP. Contraindications: HTN, elevated ICP, CHF, thyrotoxicosis, hepatic impairment. Adverse Reactions: Increased ICP(bad for spinal tap), respiratory depression, laryngospasm, hypotension, bradycardia are the more serious problems. Half-life: 2.5 hours |
|
|
Term
|
Definition
|
|
Term
|
Definition
MOA: GABA agonist to benzodiazepine receptor. Contraindications: Glaucoma, depression, shock, addictions, COPD, CHF, hepatic or renal impairment. Adverse Reactions: Apnea or cardiac arrest at high doses, addiction, GI effects. Onset: 1-5 minutes Peak Effect: Rapid Duration: 2-6 hours Half-life: 2.5 hours --takes a little while to wear off |
|
|
Term
|
Definition
MOA: GABA agonist to benzodiazepine receptor. Onset: 1-5 minutes Peak: 15-30 minutes Duration: 15-60 minutes Half-life: irregular and bimodal Cautions: Due to the great variation in response, diazepam is rarely used for conscious sedation. |
|
|
Term
|
Definition
Antiemetic MOA: Blocks alpha adrenergic and dopamine receptors. Related to haloperidol. Adverse Reactions: Drowsiness, tachycardia, lightheadedness are infrequent. Rarely oculogyric crisis or tardive dyskinesia develop. QT interval problems--dosing reworked |
|
|
Term
|
Definition
•ondansetron (Zofran) •Promethazine (Phenergan) •**compazine (prochlorperazine)--do not use in children |
|
|
Term
Giving patient to much Analgesia: What to do? |
|
Definition
Discontinue, support as necessary and monitor untill effect disipates ALWAYS decrease benzodiazapine first because we want the patient to still have pain medication (opiate) Reversal agents must be readily available
|
|
|
Term
|
Definition
MOA: Competes for opioid binding sites. Half-life: 30-80 minutes Adverse Events: Rare unless underlying condition. Patients with a history of heart disease are more prone to arrhythmias and hypertension. |
|
|
Term
|
Definition
MOA: Antagonizes benzodiazepine receptors. Contraindications: Seizures Adverse Reactions: Dizziness, diaphoresis, agitation, shivering, tachycardia, bradycardia Pregnancy: C Half-life: 54 minutes |
|
|
Term
Rapid Sequence Induction AKA Rapid Sequence Intubation |
|
Definition
•Giving a rapid sequence of pharmacologic agents to anesthetize and paralyze a patient for a brief procedure such as endotracheal intubation. Goals: establish airway and prevent aspirations minimize trauma, anxiety and pain ***want fast acting ans short lived agents*** |
|
|
Term
Pre-treatment for rapid sequence intubation |
|
Definition
--Beta-blocker: esmolol --Lidocaine--blunting cough and gag |
|
|
Term
Analgesia for Rapid sequence |
|
Definition
|
|
Term
Anesthesia Induction (Rapid Sequence Intubation) |
|
Definition
quickest: Propofol Etomidate midazolam--longer and patient usually going to ICU after procedure Ketamine--not first choice Those are in order of choice
|
|
|
Term
Neuromuscular blockade Depolarizing versus Non-Depolarizing |
|
Definition
•Depolarizing agents depolarize the NMJ causing exhaustion of acetylcholine and paralysis results. •Non-depolarizing agents block the motor endplate from acetylcholine and cause paralysis. |
|
|
Term
|
Definition
MOA: Depolarization of the NMJ resulting in paralysis. Duration: 6-10 minutes (rapid) Contraindications: Hyperkalemia or major trauma, malignant hyperthermia, cholinesterase deficiency, myasthenia gravis, glaucoma, hx of rhabdomyolysis Adverse Reactions: Cardiovascular collapse, malignant hyperthermia, anaphylaxis, rhabdomyolysis. |
|
|
Term
|
Definition
MOA: Block the motor endplate from acetylcholine transmitters without depolarization. Adverse Reactions: Hypotension, arrhythmias, bronchospasm, dizziness, flushing Half-life: 1.5 – 2 minutes (very short) |
|
|
Term
|
Definition
MOA: Block the motor endplate from acetylcholine transmitters without depolarization. Adverse Reactions: Hypotension, arrhythmias, bronchospasm, dizziness, flushing Half-life: 65-75 minutes (long and good for patients going to ICU) |
|
|
Term
|
Definition
MOA: Block the motor endplate from acetylcholine transmitters without depolarization. Adverse Reactions: Hypotension, arrhythmias, bronchospasm, dizziness, flushing Half-life: 1.4-2 hrs (long and good for patient going into ICU) |
|
|
Term
Other Neuromuscular Depolarizing Agents: |
|
Definition
•Atracurium (Tracrium): Half-life 20 minutes •Cisatracurium (Nimbex): Half-life 22-29 minutes •Rocuronium (Zemuron): Half-life 1.4-2.4 hours |
|
|
Term
|
Definition
Titrate to desired dose Decrease dose in elderly, renally and hepatic impaired patients Make sure person giving drug is familiar with the drugs effects Increased sensitivity in Peds (especially < 6mo NEVER give Meperidne to a patient when the have been on an MAO inhibitor in the last two wks.
|
|
|